Syndromic surveillance study of severe acute respiratory illness to characterise #flu & #SARSCoV2 in hospitalised patients @NHSGGC. @CVRinfo @P_H_S_Official
Clinical Characterisation of Respiratory Viral Infections among Pts with Hospitalised Severe Acute Respiratory Illness using POC Multiplex Assays
Funded by @P_H_S_Official & sponsored by @NHSGGC.
PI @DrToniHo, co-led by @djlmed. Supported by @GlasgowCRF.
📢 VACANCY | Computational Biologist/Bioinformatician 🦠
Join our brilliant team and contribute to the analysis of antiviral host-mechanisms and comparative virology datasets.
📆 Deadline: 25 August
Info: https://t.co/qymWosVoUa Ref 178592
Apply: https://t.co/kOf41PjLDo
In our latest blog, Prof Dominic Mellor, updates on the ongoing bird flu outbreak that's swept across the globe and offers advice to both the public and those who keep birds that can minimise the risk of the virus being spread.
Read to find out more 👇
https://t.co/6bQW5w0pnP
#flu cases are at an all time high ⬆️ 📈🦠, putting enormous pressures on GPs & hospitals.
Do stay at home if you are unwell, practice good hand hygiene & get vaccinated if you are eligible for the flu vaccine.
Stay safe for the festive period! 🙏
📣1st paper from @CharismaStudy now in Journal of Infection!
Near real-time severe acute respiratory illness surveillance characterising #flu and #COVID19 epidemiology in hospitalised adults, 2021-22
https://t.co/6O7rf8bvWB
@P_H_S_Official@CVRinfo@NHSGGC@GlasgowCRF
A🧵/
Thanks to @AoPgbi for my poster prize for @CharismaStudy & for a fantastic meeting! ☺️
Really enjoyed networking with fellow clinician scientists & hearing about the incredible, wide-ranging science from studying impact of space travel on kidneys to new treatments for MND.
1/4
🏥 New study | CHARISMA!
@DrToniHo is leading on a new study funded by @P_H_S_Official and sponsored by @NHSGGC which aims to clinically characterise respiratory viral infections among patients with hospitalised severe acute respiratory illness!
Follow them for more info 👇